Home / Companies / News / Covid-19 vaccine manufacturers, private hospitals face revenue loss

Covid-19 vaccine manufacturers, private hospitals face revenue loss

Back-of-the-envelope calculations show that Serum Institute of India (SII) will lose revenues worth Rs 26.25 crore a month, while Bharat Biotech would lose to the tune of Rs 45 crore a month

coronavirus, Covid-19, vaccination, vaccine

Premium

According to the revised policy, now the Centre will procure the vaccines for ages 18 and above, and will provide those to the states

Sohini Das Mumbai

4 min read Last Updated : Jun 08 2021 | 6:10 AM IST

With the Centre revising its policy and making Covid-19 vaccines free for ages 18 and above from June 21, vaccine makers and private hospitals face a loss of revenue.

Back-of-the-envelope calculations show that Serum Institute of India (SII) will lose revenues worth Rs 26.25 crore a month, while Bharat Biotech would lose to the tune of Rs 45 crore a month. This is assuming that SII is making 70 million doses of Covishield a month, while Bharat Biotech is making 40 million doses per month of Covaxin.

Both the vaccine makers did not comment on the impact of the Centre’s

Topics : Coronavirus Coronavirus Vaccine Private hospitals Vaccine Vaccination Pharma industry healthcare Serum Institute of India Bharat Biotech

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in